Mangrove Partners’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History
Bought
Maintained
Sold
Other funds holding PEPLU
SIM
MF
ACM
BFM
CIM
WC
SMA
SIA
LCM
Mangrove Partners's PEPLU Position: Q1 2022 in Review
Mangrove Partners sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2022, closing a stake of 400,000 shares — an estimated $4.07M sold.
Mangrove Partners first reported a position in PEPLU in Q4 2021 and held it in 1 quarter. The position peaked at $4.07M in Q4 2021. 15 funds tracked by Wall St. Rank hold PEPLU as of Q1 2022.
- Mangrove Partners reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
- Mangrove Partners sold 400,000 PepperLime Health Acquisition Corporation Unit shares in Q1 2022, an estimated $4.07M.
- Mangrove Partners first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 1 quarter.
- Mangrove Partners's PepperLime Health Acquisition Corporation Unit position peaked at $4.07M in Q4 2021.
- 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2022.
Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.